Related Experiment Video
Updated: Jun 3, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic value of the Rose questionnaire: a validation with future coronary events in the SMART study
S Achterberg1, S S Soedamah-Muthu, M J M Cramer
1Department of Neurology, Rudolf Magnus Institute of Neuroscience UMC Utrecht, Utrecht, The Netherlands. s.achterberg-2@umcutrecht.nl
Insights
The Rose questionnaire, used for diagnosing angina pectoris, can effectively predict future coronary events. A shorter version with key questions performs as well as the full questionnaire for risk assessment.
Area of Science:
- Cardiology
- Epidemiology
- Preventive Medicine
Background:
- The Rose questionnaire is a standard tool for diagnosing angina pectoris in epidemiological research.
- Its prognostic value for predicting future coronary events requires further investigation.
Purpose of the Study:
- To evaluate the prognostic capability of the Rose questionnaire for future coronary events.
- To compare the predictive performance of different subsets of the Rose questionnaire against the full version.
Main Methods:
- A cohort of 7916 patients with vascular disease or risk factors from the Second Manifestations of ARTerial disease (SMART) study were analyzed.
- Four definitions of angina pectoris based on the Rose questionnaire were assessed.
- Multivariable Cox regression models were used to analyze new coronary events and interventions over an average follow-up of 4.6 years.
Main Results:
- The discriminatory ability of the four Rose questionnaire definitions for coronary events was similar, with areas under the receiver-operator characteristics curves ranging from 0.708 to 0.726.
- The ability to improve risk stratification was comparable across the different definitions, indicating small differences between them.
- No significant difference in predictive performance was observed between the full Rose questionnaire and a subset of its questions.
Conclusions:
- A subset of questions from the Rose questionnaire demonstrates equivalent prognostic value for predicting coronary events compared to the full questionnaire.
- These findings suggest that a simplified Rose questionnaire can be effectively used for cardiovascular risk assessment.
Aim:
The Rose questionnaire was developed in epidemiological studies to obtain a reproducible diagnosis of angina pectoris. We studied the prognostic value of this questionnaire with respect to the occurrence of future coronary events.
Methods And Results:
We studied 7916 consecutive patients (mean age 56 years; 67% men) with clinically manifest vascular disease or cardiovascular risk factors, enrolled in the Second Manifestations of ARTerial disease (SMART) study from 1996 to 2009. At inclusion, all patients completed the Rose questionnaire. We investigated the prognostic value of four definitions of angina pectoris that were based on the following elements of the questionnaire (1) the full questionnaire; (2) three key questions concerning chest pain; (3) one question about discomfort or pain in the chest; (4) two questions about complaints when slowing down or stopping activities (the definition that is used in the SMART study). All patients were followed for new coronary events and interventions for an average of 4.6 years. Analyses were with multivariable Cox regression models. Discriminatory ability of the four definitions as assessed with areas under the receiver-operator characteristics curves was similar (range 0.708-0.726) for coronary events in isolation as well as in combination with coronary interventions. The models were assessed for their ability to improve risk stratification compared with each other; differences between definitions are small.
Conclusion:
Our data implicate that the use of a subset of questions of the Rose questionnaire performs equally well compared with the full Rose questionnaire regarding the prediction of coronary events.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT